Cite

    Gril, B. et al. (2020). HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood–tumor barrier penetration unlinked to a passive marker. Neuro-oncology. 22 (11), pp. 1625-1636. [Online].